Development of Heart Failure in Chronic Hypertensive Dahl Rats
Stefan Klotz(Centre National de la Recherche Scientifique), Daniel Burkhoff(Columbia University Irving Medical Center), Mathew S. Maurer(Alnylam Pharmaceuticals (United States)), Geping Zhang(Columbia University), Ilan Hay(Columbia University), Jie Wang(Sichuan University)
Cited by 164
Related Papers
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
|Circulation Heart Failure|2019|560
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis
|Journal of the American College of Cardiology|2016|540
The Impact of Frailty Status on Survival After Transcatheter Aortic Valve Replacement in Older Adults With Severe Aortic Stenosis
|JACC: Cardiovascular Interventions|2012|469
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2024|453
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
|New England Journal of Medicine|2024|410